Dao Wang to Coronary Artery Disease
This is a "connection" page, showing publications Dao Wang has written about Coronary Artery Disease.
Connection Strength
0.724
-
Mortality and pre-hospitalization use of low-dose aspirin in COVID-19 patients with coronary artery disease. J Cell Mol Med. 2021 01; 25(2):1263-1273.
Score: 0.302
-
Functional analysis LRP6 novel mutations in patients with coronary artery disease. PLoS One. 2014; 9(1):e84345.
Score: 0.187
-
Global Longitudinal Strain at Rest for Detection of Coronary Artery Disease in Patients without Diabetes Mellitus. Curr Med Sci. 2018 Jun; 38(3):413-421.
Score: 0.064
-
Associations of common variants at ALDH2 gene and the risk of stroke in patients with coronary artery diseases undergoing percutaneous coronary intervention. Medicine (Baltimore). 2018 May; 97(19):e0711.
Score: 0.063
-
Genome-Wide Association and Functional Studies Identify SCML4 and THSD7A as Novel Susceptibility Genes for Coronary Artery Disease. Arterioscler Thromb Vasc Biol. 2018 04; 38(4):964-975.
Score: 0.062
-
[Association of interleukin 10 gene -592C/A polymorphism with coronary artery disease]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2013 Dec; 30(6):724-8.
Score: 0.046